Innovent Biologics, Inc.
HKEX:1801.HK
39.55 (HKD) • At close November 4, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||
| Nettowinst
| -1,144.411 | -2,170.469 | -3,051.015 | -858.713 | -1,719.95 | -5,872.982 | -716.05 | -544.456 |
| Afschrijvingen & Amortisatie
| 385.103 | 319.422 | 204.747 | 85.627 | 86.367 | 64.062 | 61.101 | 54.595 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 50.385 | 402.297 | -14.535 | -42.725 | -8.934 | -41.266 |
| Aandelen Gebaseerde Vergoedingen
| 574.197 | 469.49 | 501.572 | 402.5 | 153.07 | 53.434 | 29.295 | 8.5 |
| Verandering in Werkkapitaal
| 403.389 | 309.908 | -90.283 | -334.056 | -141.261 | 420.591 | 43.151 | -11.871 |
| Vorderingen
| -430.622 | 444.925 | -493.027 | -225.339 | -242.534 | -8.544 | 0 | 0 |
| Voorraden
| 358.945 | -105.388 | -641.582 | -311.427 | -292.476 | -8.399 | -21.091 | -20.994 |
| Crediteuren
| 0 | 0 | 493.027 | 225.339 | 242.534 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 566.766 | -29.629 | 551.299 | -22.629 | 151.215 | 437.534 | 64.242 | 9.123 |
| Overige Niet-Contante Posten
| -311.412 | -847.155 | -49.547 | -5.343 | -28.164 | 4,361.601 | 99.167 | 171.505 |
| Kasstroom uit Operationele Activiteiten
| 147.81 | -1,918.804 | -2,024.843 | -307.688 | -1,664.473 | -1,016.019 | -492.27 | -362.993 |
| Investeringsactiviteiten: | ||||||||
| Investeringen in Materiële Vaste Activa
| -1,383.46 | -1,381.73 | -1,847.516 | -771.778 | -365.873 | -312.739 | -90.971 | -58.444 |
| Netto Overnames
| 0 | 0 | -630.144 | 88.712 | 70.532 | 178.598 | 4.755 | 4.217 |
| Aankoop van Beleggingen
| -9,414.467 | -10,325.704 | -10,337.888 | -11,644.979 | -4,851.299 | -786.476 | -1,116.71 | -817 |
| Verkoop/verval van Beleggingen
| 9,244.32 | 10,019.845 | 10,121.48 | 7,160.676 | 2,582.587 | 1,927.811 | 850.97 | 295.148 |
| Overige Investeringsactiviteiten
| 232.359 | 252.404 | -4.08 | -17.219 | -5.104 | -147.777 | 2.5 | 4 |
| Kasstroom uit Investeringsactiviteiten
| -998.662 | -1,435.185 | -2,698.148 | -5,184.588 | -2,569.157 | 859.417 | -349.456 | -572.079 |
| Financieringsactiviteiten: | ||||||||
| Schuldaflossingen
| -418.499 | -365 | -255 | -17 | -10 | -5 | -10 | 0 |
| Uitgifte van Gewone Aandelen
| 2,255.116 | 2,131.059 | 3,950.52 | 4,662.363 | 2,174.808 | 3,371.363 | 104.247 | 1,238.943 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 3,371.363 | 0 | -0.001 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 90.893 | 1,126.023 | 1,307.841 | 266.758 | -55.493 | 5,047.558 | -14.841 | 400.663 |
| Kasstroom uit Financieringsactiviteiten
| 2,587.257 | 2,892.082 | 5,003.361 | 4,912.121 | 2,109.315 | 4,433.863 | 89.406 | 1,639.605 |
| Overige Informatie: | ||||||||
| Effect van Wisselkoersveranderingen op Kas
| -6.877 | 118.664 | -197.14 | -569.473 | 25.267 | 63.832 | -26.91 | 22.386 |
| Netto Kasstroomverandering
| 1,729.528 | -343.243 | 83.23 | -1,149.628 | -2,099.048 | 4,341.093 | -779.23 | 726.919 |
| Kaspositie aan het Einde van de Periode
| 2,745.693 | 1,016.165 | 1,359.408 | 1,276.178 | 2,425.806 | 4,524.854 | 183.761 | 962.991 |